Isoform | Protein Position | Transcript Position | Chromosomal Position (HG38) | Chromosomal Position (HG19) |
---|---|---|---|---|
IC | 29722 | 89389;89390;89391 | chr2:178553947;178553946;178553945 | chr2:179418674;179418673;179418672 |
N2AB | 28081 | 84466;84467;84468 | chr2:178553947;178553946;178553945 | chr2:179418674;179418673;179418672 |
N2A | 27154 | 81685;81686;81687 | chr2:178553947;178553946;178553945 | chr2:179418674;179418673;179418672 |
N2B | 20657 | 62194;62195;62196 | chr2:178553947;178553946;178553945 | chr2:179418674;179418673;179418672 |
Novex-1 | 20782 | 62569;62570;62571 | chr2:178553947;178553946;178553945 | chr2:179418674;179418673;179418672 |
Novex-2 | 20849 | 62770;62771;62772 | chr2:178553947;178553946;178553945 | chr2:179418674;179418673;179418672 |
Novex-3 | None | None | chr2:None | chr2:None |
SNV | RS | DUET |
PolyPhen-2 |
Condel |
Rhapsody |
REVEL |
MVP |
Source |
MAF |
Disease |
Zygosity |
Site annotation |
mCSM PPI |
Predicted PPI site |
Comments |
AFR |
AMR |
AMS |
ASJ |
EAS |
EUR |
FIN |
MDE |
NFE |
SAS |
OTH |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
P/A | None | None | 0.001 | N | 0.276 | 0.084 | 0.139678290688 | gnomAD-4.0.0 | 2.06279E-06 | None | None | None | None | N | None | 0 | 0 | None | 0 | 0 | None | 0 | 0 | 2.70283E-06 | 0 | 0 |
P/Q | rs763050858 | -1.191 | 0.93 | N | 0.584 | 0.347 | 0.371344866733 | gnomAD-2.1.1 | 4.13E-06 | None | None | None | None | N | None | 0 | 0 | None | 0 | 0 | None | 3.38E-05 | None | 0 | 0 | 0 |
P/Q | rs763050858 | -1.191 | 0.93 | N | 0.584 | 0.347 | 0.371344866733 | gnomAD-4.0.0 | 1.61136E-06 | None | None | None | None | N | None | 0 | 0 | None | 0 | 0 | None | 0 | 0 | 0 | 1.45062E-05 | 0 |
P/S | None | None | 0.278 | N | 0.463 | 0.097 | 0.148003135375 | gnomAD-4.0.0 | 2.75038E-06 | None | None | None | None | N | None | 0 | 0 | None | 0 | 0 | None | 0 | 0 | 3.60378E-06 | 0 | 0 |
P/T | rs538120743 | -1.411 | 0.435 | N | 0.495 | 0.106 | 0.253726318573 | gnomAD-2.1.1 | 3.7E-05 | None | None | None | None | N | None | 0 | 2.05713E-04 | None | 0 | 0 | None | 3.36E-05 | None | 0 | 9E-06 | 0 |
P/T | rs538120743 | -1.411 | 0.435 | N | 0.495 | 0.106 | 0.253726318573 | gnomAD-3.1.2 | 6.57E-06 | None | None | None | None | N | None | 0 | 0 | 0 | 0 | 0 | None | 0 | 0 | 1.47E-05 | 0 | 0 |
P/T | rs538120743 | -1.411 | 0.435 | N | 0.495 | 0.106 | 0.253726318573 | 1000 genomes | 1.99681E-04 | None | None | None | None | N | None | 0 | 0 | None | None | 0 | 1E-03 | None | None | None | 0 | None |
P/T | rs538120743 | -1.411 | 0.435 | N | 0.495 | 0.106 | 0.253726318573 | gnomAD-4.0.0 | 1.12034E-05 | None | None | None | None | N | None | 0 | 1.17576E-04 | None | 0 | 0 | None | 0 | 0 | 6.79131E-06 | 3.32145E-05 | 0 |
SAV |
AlphaMissense (IC) |
AlphaMissense Class (IC) |
AlphaMissense (N2AB) |
AlphaMissense Class (N2AB) |
mCSM |
mCSM class |
PolyPhen-2 |
PolyPhen-2 Class |
Rhapsody |
Rhapsody Class |
Condel |
Condel Score |
Site annotation |
mCSM PPI |
Predicted PPI site |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
P/A | 0.0658 | likely_benign | 0.0624 | benign | -1.518 | Destabilizing | 0.001 | N | 0.276 | neutral | N | 0.488155895 | None | None | N |
P/C | 0.4993 | ambiguous | 0.5199 | ambiguous | -0.907 | Destabilizing | 0.946 | D | 0.704 | prob.delet. | None | None | None | None | N |
P/D | 0.7001 | likely_pathogenic | 0.6844 | pathogenic | -1.112 | Destabilizing | 0.834 | D | 0.537 | neutral | None | None | None | None | N |
P/E | 0.4128 | ambiguous | 0.4217 | ambiguous | -1.088 | Destabilizing | 0.712 | D | 0.564 | neutral | None | None | None | None | N |
P/F | 0.6391 | likely_pathogenic | 0.66 | pathogenic | -1.13 | Destabilizing | 0.946 | D | 0.711 | prob.delet. | None | None | None | None | N |
P/G | 0.4213 | ambiguous | 0.4008 | ambiguous | -1.858 | Destabilizing | 0.338 | N | 0.523 | neutral | None | None | None | None | N |
P/H | 0.4418 | ambiguous | 0.4627 | ambiguous | -1.326 | Destabilizing | 0.995 | D | 0.677 | prob.neutral | None | None | None | None | N |
P/I | 0.2499 | likely_benign | 0.2593 | benign | -0.675 | Destabilizing | 0.553 | D | 0.626 | neutral | None | None | None | None | N |
P/K | 0.5634 | ambiguous | 0.6017 | pathogenic | -1.067 | Destabilizing | 0.712 | D | 0.549 | neutral | None | None | None | None | N |
P/L | 0.1781 | likely_benign | 0.1814 | benign | -0.675 | Destabilizing | 0.278 | N | 0.54 | neutral | N | 0.504240068 | None | None | N |
P/M | 0.3106 | likely_benign | 0.3197 | benign | -0.511 | Destabilizing | 0.946 | D | 0.656 | prob.neutral | None | None | None | None | N |
P/N | 0.4949 | ambiguous | 0.5031 | ambiguous | -0.89 | Destabilizing | 0.946 | D | 0.681 | prob.neutral | None | None | None | None | N |
P/Q | 0.2967 | likely_benign | 0.3181 | benign | -1.033 | Destabilizing | 0.93 | D | 0.584 | neutral | N | 0.507208446 | None | None | N |
P/R | 0.4849 | ambiguous | 0.5115 | ambiguous | -0.591 | Destabilizing | 0.93 | D | 0.679 | prob.neutral | N | 0.495598651 | None | None | N |
P/S | 0.1729 | likely_benign | 0.1696 | benign | -1.478 | Destabilizing | 0.278 | N | 0.463 | neutral | N | 0.499546324 | None | None | N |
P/T | 0.1209 | likely_benign | 0.1199 | benign | -1.339 | Destabilizing | 0.435 | N | 0.495 | neutral | N | 0.500815761 | None | None | N |
P/V | 0.1702 | likely_benign | 0.1707 | benign | -0.921 | Destabilizing | 0.014 | N | 0.404 | neutral | None | None | None | None | N |
P/W | 0.8554 | likely_pathogenic | 0.8653 | pathogenic | -1.321 | Destabilizing | 0.995 | D | 0.739 | deleterious | None | None | None | None | N |
P/Y | 0.6425 | likely_pathogenic | 0.6698 | pathogenic | -1.013 | Destabilizing | 0.982 | D | 0.71 | prob.delet. | None | None | None | None | N |
Titin has multiple isoforms, the longest being the theoretical IC (inferred complete) isoform which contains all 363 in-frame titin exons. Here all isoform positions have been mapped onto the IC sequence, with an exception being the C-terminal of the much shorter novex-3 isoform. This contains the out of frame exon 48 which cannot be mapped to the other isoforms.